These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model. Hansen AB; Kirkeby S; Aasted B; Dahl K; Hansen AK; Dieperink H; Svendsen M; Kemp E; Buschard K; D'Apice AJ APMIS; 2003 Nov; 111(11):1019-26. PubMed ID: 14629268 [TBL] [Abstract][Full Text] [Related]
10. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice. Gock H; Salvaris E; Murray-Segal L; Mottram P; Han W; Pearse MJ; Goodman DJ; Cowan PJ; d'Apice AJ Xenotransplantation; 2000 Nov; 7(4):237-46. PubMed ID: 11081758 [TBL] [Abstract][Full Text] [Related]
11. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. Yin D; Ma L; Varghese A; Shen J; Chong AS J Immunol; 2002 May; 168(10):5352-8. PubMed ID: 11994494 [TBL] [Abstract][Full Text] [Related]
12. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice. Yin D; Ma L; Shen J; Byrne GW; Logan JS; Chong AS Am J Transplant; 2002 Jan; 2(1):41-7. PubMed ID: 12095055 [TBL] [Abstract][Full Text] [Related]
13. Naturally acquired anti-alpha Gal antibodies in a murine allograft model similar to delayed xenograft rejection. Salvaris E; Gock H; Han W; Murray-Segal L; Barlow H; Mottram P; Pearse M; Cowan P; Goodman D; d'Apice AJ Xenotransplantation; 2000 Feb; 7(1):42-7. PubMed ID: 10809056 [TBL] [Abstract][Full Text] [Related]
14. Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models. Wu GD; Cramer DV; Chapman FA; Wang HK; Chien K; Cole J; Makowka L Transplant Proc; 1993 Feb; 25(1 Pt 1):464-5. PubMed ID: 8438380 [No Abstract] [Full Text] [Related]
15. Reduction of anti-Gal alpha 1-3Gal natural antibodies in sera of alpha 1,3-galactosyltransferase-deficient mice receiving Gal-positive bone marrow transplantation. Ohdan H; Yang YG; Sykes M Transplant Proc; 1999; 31(1-2):945-6. PubMed ID: 10083418 [No Abstract] [Full Text] [Related]
16. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223 [TBL] [Abstract][Full Text] [Related]
17. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. Xu H; Yin D; Naziruddin B; Chen L; Stark A; Wei Y; Lei Y; Shen J; Logan JS; Byrne GW; Chong AS J Immunol; 2003 Feb; 170(3):1531-9. PubMed ID: 12538718 [TBL] [Abstract][Full Text] [Related]
18. Effect of primary xenograft or allograft on the rejection of a subsequent allograft. Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376 [No Abstract] [Full Text] [Related]
19. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. Yin D; Zeng H; Ma L; Shen J; Xu H; Byrne GW; Chong AS J Immunol; 2004 Jun; 172(12):7235-8. PubMed ID: 15187097 [TBL] [Abstract][Full Text] [Related]
20. Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts. Sun H; Wakizaka Y; Rao AS; Pan F; Madariaga J; Park IY; Celli S; Fung JJ; Starzl TE; Valdivia LA Transplant Proc; 1996 Apr; 28(2):732. PubMed ID: 8623370 [No Abstract] [Full Text] [Related] [Next] [New Search]